Cargando…
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The patients were health care workers who were 32 to 54 years of age...
Autores principales: | Schultz, Nina H., Sørvoll, Ingvild H., Michelsen, Annika E., Munthe, Ludvig A., Lund-Johansen, Fridtjof, Ahlen, Maria T., Wiedmann, Markus, Aamodt, Anne-Hege, Skattør, Thor H., Tjønnfjord, Geir E., Holme, Pål A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112568/ https://www.ncbi.nlm.nih.gov/pubmed/33835768 http://dx.doi.org/10.1056/NEJMoa2104882 |
Ejemplares similares
-
Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2023) -
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
por: Holm, Sverre, et al.
Publicado: (2021) -
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
por: Hetland, Geir, et al.
Publicado: (2022) -
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021) -
Depression following ChAdOx1-S/nCoV-19 vaccine
por: Uvais, N.A.
Publicado: (2022)